Keyphrases
Hypoxia-inducible Factor
100%
Myocardial Protection
100%
Renal Protection
100%
Prolyl Hydroxylase Inhibitor
100%
Prolyl Hydroxylase
66%
Fibrosis
33%
Kidney Disease
16%
Cardiovascular Disease
16%
Regulatory Subunit
16%
Gatekeepers
16%
Heart Failure
16%
Angiogenesis
16%
Oxidative Damage
16%
Endogenous Production
16%
Erythropoietin
16%
Clinical Potential
16%
Ischemic Injury
16%
Ischemic Heart Disease
16%
Therapeutic Approaches
16%
Hypoxia
16%
Hypoxia-inducible factor-1α (HIF-1α)
16%
Adaptive Response
16%
Energy Metabolism
16%
Cardiac Hypertrophy
16%
Iron Absorption
16%
Cardiovascular Effects
16%
Pharmacological Agents
16%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
16%
Hypoxia Response
16%
Selective Inhibition
16%
Cell Signaling Pathways
16%
Hepcidin
16%
Inflammation Injury
16%
Cardiovascular Research
16%
Apoptosis Inflammation
16%
Hypoxia-inducible Factor 2
16%
Pharmacology, Toxicology and Pharmaceutical Science
Hypoxia Inducible Factor
100%
Prolyl Hydroxylase Inhibitor
100%
Procollagen Proline 2 Oxoglutarate 4 Dioxygenase
57%
Inflammation
28%
Hypoxia
28%
Injury
28%
Fibrosis
28%
Kidney Disease
14%
Cardiovascular Disease
14%
Prothrombin
14%
Heart Failure
14%
Ischemic Heart Disease
14%
Hypoxia Inducible Factor 1
14%
Heart Ventricle Hypertrophy
14%
Sodium Glucose Cotransporter 2 Inhibitor
14%
Erythropoietin
14%
Heterodimer
14%
Hepcidin
14%